Healthcare provider profile · identity verified

Griffith Guerry Walters, M.D.

Family Practice · TROY, AL · NPI 1801829643

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	325	99
Amoxicillin	Amoxicillin	293	200
Atorvastatin Calcium	Atorvastatin Calcium	276	95
Prednisone	Prednisone	273	161
Tizanidine Hcl	Tizanidine Hcl	268	79
Albuterol Sulfate Hfa	Albuterol Sulfate	267	92
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	261	56
Tramadol Hcl	Tramadol Hcl	260	70
Gabapentin	Gabapentin	237	53
Diclofenac Sodium	Diclofenac Sodium	223	84
Omeprazole	Omeprazole	223	62
Pantoprazole Sodium	Pantoprazole Sodium	223	86
Famotidine	Famotidine	211	68
Methylprednisolone	Methylprednisolone	208	156
Rosuvastatin Calcium	Rosuvastatin Calcium	171	59
Pravastatin Sodium	Pravastatin Sodium	161	41
Fenofibrate	Fenofibrate	158	48
Potassium Chloride	Potassium Chloride	145	40
Pregabalin	Pregabalin	135	25
Jardiance	Empagliflozin	134	32
Losartan Potassium	Losartan Potassium	133	44
Furosemide	Furosemide	130	43
Levothyroxine Sodium	Levothyroxine Sodium	127	37
Fluconazole	Fluconazole	124	62
Metformin Hcl	Metformin Hcl	123	34
Lisinopril	Lisinopril	120	34
Alendronate Sodium	Alendronate Sodium	119	35
Clonazepam	Clonazepam	118	20
Hydrochlorothiazide	Hydrochlorothiazide	102	34
Clopidogrel	Clopidogrel Bisulfate	96	36
Trazodone Hcl	Trazodone Hcl	96	30
Carvedilol	Carvedilol	95	31
Glipizide	Glipizide	92	22
Tamsulosin Hcl	Tamsulosin Hcl	87	28
Levofloxacin	Levofloxacin	86	58
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	85	28
Alprazolam	Alprazolam	82	15
Ezetimibe	Ezetimibe	78	23
Tradjenta	Linagliptin	77	16
Metoprolol Succinate	Metoprolol Succinate	73	22
Temazepam	Temazepam	73	18
Azithromycin	Azithromycin	71	55
Etodolac	Etodolac	70	35
Meclizine Hcl	Meclizine Hcl	70	28
Eliquis	Apixaban	68	19
Citalopram Hbr	Citalopram Hydrobromide	66	21
Oseltamivir Phosphate	Oseltamivir Phosphate	65	60
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	62	16
Duloxetine Hcl	Duloxetine Hcl	61	20
Meloxicam	Meloxicam	61	24
Montelukast Sodium	Montelukast Sodium	61	20
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	57	19
Hydralazine Hcl	Hydralazine Hcl	57	20
Metoprolol Tartrate	Metoprolol Tartrate	56	19
Januvia	Sitagliptin Phosphate	53	15
Mounjaro	Tirzepatide	52	suppressed
Nifedipine Er	Nifedipine	52	19
Ondansetron Odt	Ondansetron	52	24
Hydroxyzine Hcl	Hydroxyzine Hcl	51	16
Clindamycin Hcl	Clindamycin Hcl	50	40
Zolpidem Tartrate	Zolpidem Tartrate	50	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	48	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	18
Nitroglycerin	Nitroglycerin	46	23
Promethazine Hcl	Promethazine Hcl	46	18
Loperamide	Loperamide Hcl	45	26
Oxybutynin Chloride Er	Oxybutynin Chloride	45	13
Quetiapine Fumarate	Quetiapine Fumarate	45	15
Donepezil Hcl	Donepezil Hcl	44	18
Lorazepam	Lorazepam	44	suppressed
Methocarbamol	Methocarbamol	44	28
Valsartan	Valsartan	44	12
Linzess	Linaclotide	43	20
Ozempic	Semaglutide	43	suppressed
Sertraline Hcl	Sertraline Hcl	43	15
Metformin Hcl Er	Metformin Hcl	41	12
Clonidine Hcl	Clonidine Hcl	40	12
Dicyclomine Hcl	Dicyclomine Hcl	39	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	38	27
Buspirone Hcl	Buspirone Hcl	37	16
Escitalopram Oxalate	Escitalopram Oxalate	37	12
Glipizide Er	Glipizide	36	12
Valacyclovir	Valacyclovir Hcl	36	18
Ondansetron Hcl	Ondansetron Hcl	35	18
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Bupropion Xl	Bupropion Hcl	32	12
Fluticasone Propionate	Fluticasone Propionate	31	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Levetiracetam	Levetiracetam	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	19
Bumetanide	Bumetanide	28	15
Finasteride	Finasteride	25	suppressed
Metronidazole	Metronidazole	25	16
Mirtazapine	Mirtazapine	25	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Entresto	Sacubitril/Valsartan	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Klor-Con 10	Potassium Chloride	22	suppressed
Lidocaine	Lidocaine	22	suppressed
Cefdinir	Cefdinir	21	17
Glimepiride	Glimepiride	21	suppressed
Testosterone Cypionate	Testosterone Cypionate	21	suppressed
Baclofen	Baclofen	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Nabumetone	Nabumetone	20	17
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	20	15
Ramipril	Ramipril	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	20	suppressed
Colestipol Hcl	Colestipol Hcl	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Repatha Pushtronex	Evolocumab	19	suppressed
Rybelsus	Semaglutide	19	suppressed
Simvastatin	Simvastatin	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Divalproex Sodium	Divalproex Sodium	18	suppressed
Estradiol	Estradiol	18	suppressed
Mupirocin	Mupirocin	18	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	13
Ketoconazole	Ketoconazole	17	13
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Allopurinol	Allopurinol	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Primidone	Primidone	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Oxcarbazepine	Oxcarbazepine	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Atenolol	Atenolol	13	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	13	suppressed
Diazepam	Diazepam	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Lagevrio (Eua)	Molnupiravir	13	13
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Tivicay	Dolutegravir Sodium	13	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Tresiba	Insulin Degludec	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Cefuroxime	Cefuroxime Axetil	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Praluent Pen	Alirocumab	11	suppressed
Terconazole	Terconazole	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error